Skip to Main Content
BioNano Monographs

Biocompatible Nanomaterials for Targeted and Controlled Delivery of Biomacromolecules

Editor
D. Kapoor
D. Kapoor
Search for other works by this author on:
S. Dhawan
S. Dhawan
Search for other works by this author on:
ISBN:
9780791860113
No. of Pages:
55
Publisher:
ASME Press
Publication date:
2013

In 2006, United States Food and Drugs Administration (FDA) included nanotechnology in its Critical Task Force and formed a Nanotechnology Task Force to determine the regulatory approaches that would enable to continue the development of innovative, safe and effective FDA-regulated products, which use nanoscale materials (http://www.fda.gov/nanotechnology/). In July of 2007, the task force released its first nanotechnology report in which the task force highlighted scientific and regulatory issues involving nanoscale material containing products. The scientific issues were focused on understanding the interactions of nanoscale materials with biological systems and the adequacy of current testing approaches for assessing safety and quality of products containing nanoscale materials [6].

You do not currently have access to this chapter.
Close Modal
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close Modal
Close Modal